Organogenesis
Price & Volume
Stats
See more52W Range | $2.28-$6.71 |
Market Cap | $411M |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $458.7M |
Revenue Growth (YoY) | -21.2% |
Gross Profit (12 Mos) | $347.9M |
Diluted EPS | -$0.16 |
News
See moreYahoo Finance • 10 days ago
Monday 6/9 Insider Buying Report: AMPY, ORGO
Yahoo Finance • 2 months ago
Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
Yahoo Finance • 2 months ago
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
Yahoo Finance • 5 months ago
Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025
About
CEO | Mr. Gary S. Gillheeney Sr. |
Address | 85 Dan Road, Canton, MA, United States, 02021 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 869 |
